Immune function assays as indicators of chromate exposure. by Snyder, C A & Valle, C D
Environmental Health Perspectives
Vol. 92, pp. 83-86, 1991
Immune Function Assays As Indicators of
Chromate Exposure
by Carroll A. Snyder* and Celeste D. Valle*
The potential immunomodulatory effects of chromium were investigated using a series of in
vitro and in vivo studies. Chromium (as K2CrO4) in concentrations spanning five orders of mag-
nitude was added in vitro to T-lymphocyte (concanavalin A) and B-lymphocyte (liposaccharide)
mitogen cultures and was found to inhibit T-lymphocyte responses at all concentrations tested
and to inhibit B-lymphocyte responses at all but the lowest concentration tested (0.01 mg/L).
When the same concentrations of chromium were employed in mixed lymphocyte cultures,
antigen-induced thymidine uptake was inhibited at the highest concentrations (100 mg/bL- mg/
L), enhanced at 0.1 mg/L, and equal to control values at lower concentrations. Splenocytes
isolated from rats exposed to K2CrO4 in drinking water exhibited enhanced responses to T- and
B-lymphocyte mitogens. The addition of 0.1 mg/L of chromium to a mixed lymphocyte culture
containing splenocytes taken from chromium-exposed rats increased by 5-fold the uptake of
thymidine by these cells. These increased responses of cells from chromium-exposed rats may
indicate chromium-induced sensitization and may possibly be used as a biological marker for
chromium exposure.
Introduction
Although some heavy metals, notably mercury, lead,
nickel, and zinc, have been shown to alter immune-
associated processes (1-3), the immunological conse-
quences of chromium exposure have not been studied
extensively. We wished to determine whether or not
chromium could alter certain immune function assays
as part of a larger program designed to assess the utility
of these assays as markers for chemical exposure. As a
first approach, the effects of chromium (as K2CrO4) at
concentrations spanning five orders of magnitude (100
mg/L-0.01 mg/L) were assessed in vitro on the mito-
gen-induced proliferation of T- and B-lymphocytes and
on the antigen-induced proliferation of T-lymphocytes
in one-way mixed lymphocyte cultures. Subsequently,
splenocytes from rats exposed to K2CrO4 in drinking
water were isolated, and the responses of these cells to
B- and T-lymphocyte mitogens and to the proliferative
stimuli in mixed lymphocyte cultures were assessed. In
all studies proliferation was measured by tritiated
thymidine uptake.
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In the in vitro studies, an unremarkable dose response
was observed in the mitogen assays. However, in the
mixed lymphocyte cultures, thymidine uptake was en-
hanced at 0.1 mg/L chromium. Higher concentrations
resulted in almost no uptake of thymidine, while lower
concentrations had no effect on thymidine uptake. Thus,
in a narrow concentration range, in vitro chromium ap-
parently enhanced the proliferation of T-lymphocytes
in the mixed lymphocyte culture.
In the in vivo studies there was more evidence for
chromium-induced enhancement of lymphocyte prolif-
eration. Splenocytes taken from chromate-exposed rats
showed enhanced thymidine uptake at day 2 in both the
B- and T-lymphocyte mitogen assays and in the mixed
lymphocyte culture assay. Of particular note, the addi-
tion of 0.1 mg/L chromium to the mixed lymphocyte
culture increased by 5-fold the thymidine update of
splenocytes taken from chromium-exposed rats. This
latter result may be indicative of chromium-induced
sensitization which, if true, may form the basis of a
method for assessing chromium exposure.
Methods
Splenocytes from Fischer 344 rats (Charles River,
Wilmington, MA) were used throughout the studies.
Splenocytes from Sprague-Dawley rats (Charles River,
Wilmington, MA) served as stimulator cells in the mixed
lymphocyte cultures. Spleens were removed under
sterile conditions and placed in RPMI (Gibco, GrandSNYDER AND VALLE
Island, NY) media. Spleens were then pressed through
stainless-steel screens and the cells gently aspirated.
Cells were then transferred to test tubes, and tissue
clumps were allowed to settle. The supernates were
washed one time and the cells in the supernates were
counted.
Mitogen Assays
Mitogen assays were performed in RPMI 1640 media.
For the concanavalin A (ConA) assays, RPMI 1640 was
supplemented with 5% fetal calfserum, 0.5% gentamicin,
and 1% glutamine. ConA powder was added at 10 ,ug/
mL. For the liposaccharide (LPS) assays, RPMI 1640
was supplemented with 3 mM glutamine, 25 mM Hepes
buffer, 1% 2-mercaptoethanol, 1% penicilline/strepto-
mycin/neomycin and 5% fetal calfserum. LPS was added
to this media at a concentration of 100 ,ug/mL.
For both mitogen assays, cells were plated in micro-
titer plates at 2 x 105 cells in 0.2 mL per well. Chromium
as K2CrO4 (J. T. Baker, Philipsburg, NJ) was added at
appropriate concentrations. Cells were cultured in 8 to
12 replicates in 5% CO2atmosphere for up to 72 hr. At
18 hrbefore harvesting, cells were pulsed with tritiated
methylthymidine (specific activity, 20 Ci/mmole) (New
England Nuclear, Boston, MA) at 1 iCi/well. Cells were
harvested using an automated cell harvester (Cambridge
Technology, Cambridge, MA) onto glass fiber filters.
Each filter was placed into a mini-scintillation vial, and
7 mL of scintillation fluid was added. After dark adap-
tation, each vial was counted for 5 min in a scintillation
counter (Wallac Oy Co., Turku, Findland).
One-Way Mixed Lymphocyte Cultures
One-way mixed lymphocyte cultures were performed
in RPMI 1640 supplemented as described for a ConA
assay. Stimulator splenocytes from outbred Sprague-
Dawley rats were incubated in mitomycin C (Sigma, St.
Louis, MO) for 40 min at 37°C. These cells were then
washed three times and mixed with Fischer 344
splenocytes at a ratio of2:1 (4 x 105:2 x 105). Cells were
then cultured in 8 to 12 replicates in the wells of
microtiter plates in 0.2 mL of media. Cells were incu-
bated at 370C in a 5% CO2 atmosphere for up to 5 days.
Pulsing, harvesting, and scintillation counting were
performed as described above for the mitogen assays.
Animals undergoing the in vivo exposures to chro-
mium were housed singly in wire mesh cages. Chro-
mium, as K2CrO4, was dissolved in distilled water and
placed in standard rat water bottles. Animals were al-
lowed food (Purina Lab Chow) and fluid ad libitum.
Control rats received distilled water ad libitum. Chro-
mate solutions and water were changed weekly.
Results
The responses ofrat splenocytes to T- (ConA) and B-
(LPS) lymphocyte mitogens in the presence of various
concentrations of chromium are given in Figure 1. Al-
most no response to either mitogen was observed until
concentrations of chromium were reduced to 0.1 mg/L.
At this concentration and at 0.01 mg/L chromium, the
reponses to the T-lymphocyte mitogen appeared to be
inhibited by the chromium to a greater extent than the
responses to the B-lymphocyte mitogen.
The responses of rat splenocytes to the antigenic
stimuli of one-way mixed lymphocyte cultures in the
presence of various concentrations of chromium are
given in Figure 2. Similar to the responses observed
with the mitogen-induced stimulations, there were es-
sentially no responses observed until concentrations of
chromium were reduced to 0.1 mg/L. At this concentra-
tion, there was an increase in uptake of thymidine. At
lower concentrations, uptake to thymidine was equal to
control values.
The T-lymphocyte mitogen (ConA) responses of
splenocytes isolated from rats exposed to chromium in
drinking water are shown in Figure 3. Splenocytes taken
from rats exposed to 200 mg/L chromium showed
depressed levels of response throughout the 3 days of
culture. However, splenocytes taken from rats exposed
to 100 mg/L chromium showed elevated levels of re-
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FIGURE 1. Effect ofin vitro chromate on mitogen-stimulated prolifera-
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FIGURE 2. Effect ofin vitro chromate on mixed lymphocyte response.
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FIGURE 3. Effect of 3-week in vivo chromate exposure on ConA-
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FIGURE 4. Effect of 3-week in vivo chromate exposure on LPS-
induced proliferative activity.
sponse at days 1 and 2 of culture and response equal to
that ofcontrol on day 3.
The B-lymphocyte mitogen (LPS) responses of
splenocytes isolated from chromate-exposed rats are
shown in Figure 4. Splenocytes taken from rats exposed
to 200 mg/L chromium showed essentially the same re-
sponses as those splenocytes isolated from control rats.
Splenocytes taken from rats exposed to 100 mg/L chro-
mium exhibited an elevated response at day 2 ofculture
but showed responses equal to those ofcontrols at days
1 and 3. As observed in the in vitro chromium experi-
ments, lymphocytes responding to LPS appear to be
more resistant to the effects ofchromium than lympho-
cytes responding to ConA.
The mixed lymphocyte culture responses of
splenocytes taken from rats exposed to 100 mg/L chro-
mium over 10 weeks are shown in Figure 5. In this
experiment the samples of splenocytes from chromium
or control rats were divided, and some cells were cul-
tured in the presence of0.1 mg/L chromium in addition
to the mitomycin-c-treated Sprague-Dawley splenocytes
(stimulator cells). Control cells not cultured with added
chromium show a gradual dimunion ofthymidine uptake
over the course ofthe culture period. However, control
cells cultured with added chromium show an uptake of
thymidine that is substantially higher than that exhib-
ited by control cells cultured without added chromium.
Moreover, there is no indication ofa dimunition ofthy-
midine uptake over the course of the culture period in
control cells cultured with added chromium. Cells taken
from chromium-exposed rats and cultured without added
chromium show increased uptake ofthymidine relative
to control cells cultured without added chromium, but
there appears to be a gradual decline in thymidine up-
take at days 4 and 5 ofculture. In sharp contrast to the
other cells and culture conditions, cells taken from
chromium-exposed rats and cultured with added chro-
mium show a marked elevation in thymidine uptake
that increases dramatically during the culture period.
Eventually, the uptake of thymidine by these cells ex-
ceeds by more than 5-fold the thymidine taken up by
cells taken from chromium-exposed rats but cultured
without added chromium.
Discussion
A unifying explanation for these results is that chro-
mium reacts with lymphocyte cell surface proteins,
thereby altering the responses of the cells to various
stimuli. In the in vitro mitogen assay (Fig. 1), chromium
may react with the cell surface receptors for the mito-
gens, thereby blocking the proliferation effects of the
mitogens. At the higher concentrations, chromium may
also become internalized within the cell and react with
proteins responsible forreplication.
Chromium alteration of cell surface proteins would
also explain the enhanced proliferation observed in the
mixed lymphocyte reaction at an in vitro chromium
concentration of 0.1 mg/L. At this concentration the
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cell surface proteins of the stimulator cells may be al-
tered by reaction with chromium such that these cells
become more antigenic, thereby eliciting a greater pro-
liferative response by the effector cells. Alternately,
proteins on the surfaces of some of the effector cells
may be altered by reaction with chromium such that
these cells are now antigenic and elicit a proliferation
response from nonaffected effector cells.
Such alterations of cell surface protein and their
attendant antigenic responses would also explain the
enhanced mitogen-induced proliferation observed in cells
taken from rats exposed to chromium in vivo. After 3
weeks of chromium exposure, populations of certain
T-lymphocyte subsets could be sufficiently enlarged such
that a greater response to a T-lymphocyte mitogen
might be elicited (Fig. 3). The higher concentration of
chromium (200 mg/L) is clearly toxic and may be lethal
to the lymphocytes or block their replication by mecha-
nisms discussed above. The lower concentration (100
mg/L), however, may induce a growth of certain T-
lymphocyte populations as a result ofantigenic stimuli.
Because activated T-lymphocytes are involved in the
activation of B-lymphocytes (4), a population of T-lym-
phocytes responding to chromium-induced antigenic
stimuli might also expand the B-lymphocyte population.
This in turn could lead to enhanced responsiveness to
the B-lymphocyte mitogen LPS (Fig. 4).
Perhaps the strongest evidence for chromium-induced
activation of T-lymphocytes is given in Figure 5. The
responses of splenocytes taken from rats exposed to
chromium and cultured with additional chromium ap-
pear to be classic sensitization responses. Ten weeks of
exposure to 100 mg/L chromium may have induced a
subpopulation of T-lymphocytes that expands rapidly
in the presence of chromium or a chromium hapten.
Such a phenomenon has been observed in some indi-
viduals exhibiting nickel contact dermatitis (5). In these
cases, clones of lymphocytes have been isolated that
will proliferate in the presence ofnickel ions but not in
the presence ofother metal ions. Thus, some individuals
exhibit sensitization to nickel salts. This same phenom-
enon may have occurred in the rats exposed to chro-
mium. If this is true, it may be possible to use this
phenomenon as a marker for toxic metal exposure.
Lymphocytes from individuals exhibiting a toxic re-
sponse may be cloned and the clones grown in the pres-
ence of a number of different metal ions. Thus, it may
be possible to identify a metal inducing toxic responses
from blood samples taken from affected individuals. Such
possibilities are under investigation in this laboratory.
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